We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

24 Jul 2026 - 26 Jul 2026
05 Aug 2026 - 07 Aug 2026

Immunoassay for Quantitative Analysis of Tacrolimus

By HospiMedica staff writers
Posted on 25 Sep 2001
An immunoassay for in vitro quantitative analysis of tacrolimus and metabolite in human whole blood is designed as an aid in the management of tacrolimus therapy in liver and kidney transplant patients. More...
Called Emit 2000 Tacrolimus, the assay uses the Enzyme Multiplied Immunoassay Technique (EMIT).

Tacrolimus is a calcineurin inhibitor with selective action on T lymphocytes and is used as a primary or rescue immunosuppressant. However, the drug has a narrow range of safe and effective therapy. Inadequate levels may result in transplant rejection, while high levels are associated with many side effects. Due to the narrow therapeutic range of tacrolimus and also because of drug potency, absorption variability, and compliance issues, drug monitoring is recommended.

The new assay is the product of Dade Behring (Deerfield, IL, USA). With this new assay, the company can now offer a broad assay menu of liquid ready-to-use reagents and calibrators on just one analyzer. This menu includes the Emit 2000 Cyclosporine assay, Mycophenolic Acid assay, and the Tacrolimus assay.




Related Links:
Dade Behring

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Surgical System
Stealth AXiS
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.